PEVYCOR
LIVE

Serial Number

99792686

Owner

Aligos Therapeutics, Inc.

Attorney

Rosaleen H. Chou

Filing Date

Apr 28, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PEVYCOR Trademark

Serial Number: 99792686

PEVYCOR is a trademark filed by Aligos Therapeutics, Inc. on April 28, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Aligos Therapeutics, Inc. (7 trademarks)

1 Corporate Drive, 2nd Floor
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

April 28, 2026

Registration Date

Not Registered

Goods & Services

Scientific research in the field of virology and hepatology; Research and development in the field of pharmaceutical research and development; Pharmaceutical research in the field of antiviral therapeutics; Drug discovery services; Pharmaceutical drug development services; Research and development services in the field of pharmaceutical preparations; Research and development of new products in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Clinical research in the field of treatment of viral, liver, and metabolic diseases; Medical and scientific research in the field of viral, liver, and metabolic diseases; Scientific research in the field of pharmaceuticals; Pharmaceutical research services; Pharmaceutical product evaluation

Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of liver-related diseases; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of chronic hepatitis B virus (HBV) infection; Pharmaceutical preparations for the treatment of chronic hepatitis D virus infection; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for the treatment of rare viral diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for viral diseases; Therapeutic biological preparations for use in industry and science

Filing History

APPLICATION FILING RECEIPT MAILED
Apr 28, 2026 MAFR
NEW APPLICATION ENTERED
Apr 28, 2026 NWAP